Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Cytosorbents (CTSO) over the last 15 years, with Q3 2025 value amounting to $322000.0.

  • Cytosorbents' Change in Inventory rose 12721.89% to $322000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $899534.0, marking a year-over-year increase of 56362.27%. This contributed to the annual value of -$500466.0 for FY2024, which is 17307.13% down from last year.
  • According to the latest figures from Q3 2025, Cytosorbents' Change in Inventory is $322000.0, which was up 12721.89% from $726198.0 recorded in Q2 2025.
  • Cytosorbents' 5-year Change in Inventory high stood at $996441.0 for Q3 2021, and its period low was -$1.7 million during Q1 2023.
  • Moreover, its 5-year median value for Change in Inventory was $297263.0 (2023), whereas its average is $103602.9.
  • In the last 5 years, Cytosorbents' Change in Inventory surged by 53582096.77% in 2021 and then plummeted by 31117.33% in 2023.
  • Cytosorbents' Change in Inventory (Quarter) stood at $251496.0 in 2021, then plummeted by 293.21% to -$485918.0 in 2022, then soared by 159.38% to $288549.0 in 2023, then crashed by 220.42% to -$347466.0 in 2024, then soared by 192.67% to $322000.0 in 2025.
  • Its Change in Inventory was $322000.0 in Q3 2025, compared to $726198.0 in Q2 2025 and $198802.0 in Q1 2025.